Mostrar el registro sencillo del ítem
dc.contributor.author
Urtreger, Alejandro Jorge
dc.contributor.author
Grossoni, Valeria C.
dc.contributor.author
Falbo, Karina B.
dc.contributor.author
Kazanietz, Marcelo Gabriel
dc.contributor.author
Bal, Elisa Dora
dc.date.available
2022-07-18T16:59:11Z
dc.date.issued
2005-01
dc.identifier.citation
Urtreger, Alejandro Jorge; Grossoni, Valeria C.; Falbo, Karina B.; Kazanietz, Marcelo Gabriel; Bal, Elisa Dora; Atypical protein kinase C-ζ modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells; Wiley-liss, div John Wiley & Sons Inc.; Molecular Carcinogenesis; 42; 1; 1-2005; 29-39
dc.identifier.issn
0899-1987
dc.identifier.uri
http://hdl.handle.net/11336/162372
dc.description.abstract
In this paper, we investigated whether protein kinase C-ζ (PKCζ), a member of the atypical PKC family, induces phenotypic alterations associated with malignant transformation and tumor progression in mammary cells. The stable overexpression of PKCζ in immortalized mammary epithelial cells (NMuMG), activates the mitogenic extracellular signal-regulated kinase (ERK) pathway, enhanced clonal cell growth and exerts profound effects on proteases secretion. The effect on proteases expression seems to be specific for urokinase-type plasminogen activator and metalloproteinase-9 (MMP-9) because no modulation in MMP-2 and MMP-3 production could be detected. In addition, our experiments demonstrated that PKCζ overexpression markedly altered the adhesive, spreading, and migratory abilities of NMuMG cells. The overexpression of this enzyme was not sufficient to confer an ancho rage-independent growth capacity. An extensive mutational analysis of PKCζ revealed that the effects observed in NMuMG cells were strictly dependent on the kinase (catalytic) domain of the enzyme. Taken together, these results suggest that in mammary cells PKCζ modulates several of the critical events involved in tumor development and dissemination through the activation of mitogen activated protein kinase (MAPK)XERK pathway.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Wiley-liss, div John Wiley & Sons Inc.
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
ERK1/2 MAPK PATHWAY
dc.subject
METALLOPROTEINASES
dc.subject
PKCΖ
dc.subject
UROKINASE
dc.subject.classification
Oncología
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Atypical protein kinase C-ζ modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2022-07-15T15:22:17Z
dc.journal.volume
42
dc.journal.number
1
dc.journal.pagination
29-39
dc.journal.pais
Estados Unidos
dc.journal.ciudad
NY, United States
dc.description.fil
Fil: Urtreger, Alejandro Jorge. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
dc.description.fil
Fil: Grossoni, Valeria C.. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
dc.description.fil
Fil: Falbo, Karina B.. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
dc.description.fil
Fil: Kazanietz, Marcelo Gabriel. University of Pennsylvania; Estados Unidos
dc.description.fil
Fil: Bal, Elisa Dora. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay; Argentina
dc.journal.title
Molecular Carcinogenesis
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/10.1002/mc.20066
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/mc.20066
Archivos asociados